A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)

A Real-World Study of Atezolizumab in Combination With Platinum-Based Doublet Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-IIIB NSCLC

NCT05991206 ·Status: RECRUITING

Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]

NCT04059887 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Clinical Real World Outcomes of Lorlatinib After Alectinib in ALK-Positive NSCLC Japanese Patients

NCT04979988 ·Status: COMPLETED

A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC

NCT05896059 ·Status: RECRUITING ·Phase: PHASE2

A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT03563716 ·Status: COMPLETED ·Phase: PHASE2

Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer

NCT04665856 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer

NCT05047250 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

An Exploratory Clinical Study of TILs in the Treatment of Recurrent / Refractory Non-small Cell Lung Cancer (NSCLC)

NCT04919616 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Phase 2 Study of Brigatinib in Japanese Participants With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC)

NCT03410108 ·Status: COMPLETED ·Phase: PHASE2

Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer

NCT04977791 ·Status: RECRUITING

Real-world Study of Local Therapy Changes During 1L Lorlatinib in Unresectable ALK+ NSCLC

NCT06690541 ·Status: NOT_YET_RECRUITING

A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene

NCT04395677 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

NCT04294810 ·Status: COMPLETED ·Phase: PHASE3

Real-World Study of Iruplinalkib in the Treatment of ALK-Positive Non-Small Cell Lung Cancer

NCT05991895 ·Status: RECRUITING

Tumor Microenvironment Surveillance on Simultaneous Liver Metastases Extensive Stage Small Cell Lung Cancer

NCT05055999 ·Status: COMPLETED

A Study to Investigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT03922997 ·Status: COMPLETED ·Phase: PHASE3

Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC

NCT05798663 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

JS001 Combination Therapy in NSCLC Negative Driving Gene After First-line Chemotherapy.

NCT04459663 ·Status: UNKNOWN ·Phase: PHASE2

A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer

NCT00585533 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC

NCT05394831 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of Atezolizumab in Combination With Bevacizumab in Patients With EGFR Mutation Positive Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer

NCT04426825 ·Status: COMPLETED ·Phase: PHASE2

Erlotinib as Neoadjuvant Treatment in Patients With Stage ⅢA N2 NSCLC With Activating EGFR Mutation.

NCT01217619 ·Status: COMPLETED ·Phase: PHASE2

A Trial of AK104 Plus Anlotinib in NSCLC

NCT04646330 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients

NCT05636267 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC

NCT03703596 ·Status: UNKNOWN ·Phase: PHASE2